Rooting for a come-from-behind win, Blackstone infuses $330M into Sanofi's CD38 development plan - Endpoints News
3/15/2022 12:00:00 AM3 years 1 month ago
by Amber Tong
by Amber Tong
Sanofi is getting a little bit of help to expand its Sarclisa franchise, with Blackstone Life Sciences putting down close to $330 million (€300 million) to fund clinical trials and related costs for a subcutaneous formulation of the drug. In exchange, Blackst…
Sanofi is getting a little bit of help to expand its Sarclisa franchise, with Blackstone Life Sciences putting down close to $330 million (300 million) to fund clinical trials and related costs for a… [+620 chars]
full article...